Given Imaging sues Intromedic for patent infringement; GI Dynamics adds to executive team;

> Given Imaging ($GIVN) has filed a patent infringement suit against Intromedic in Seoul's Central District Court. Given believes Intromedic's capsule endoscope, marketed as MiroCam, infringes two Korean patents. Meanwhile, Intromedic has begun proceedings before the Korean Intellectual Property Office to invalidate the two patents asserted by Given. Given release

> GI Dynamics has named Mark Twyman to the newly created role of chief commercial officer. He will be responsible for executing GI Dynamics' global commercial strategy, including overseeing the expansion of the sales and marketing efforts to commercialize the EndoBarrier. GI Dynamics release

> Tegal Corporation ($TGAL) has invested $300,000 in NanoVibronix, which uses surface acoustic wave technology that transmits low-intensity, low-frequency waves through skin, tissue and other soft materials to treat chronic wounds. Report

> W. L. Gore & Associates has received FDA's nod for the 23- and 27-mm diameter sizes of the contralateral leg component of the GORE EXCLUDER endoprosthesis for treatment of abdominal aortic aneurysms. Gore release

> Nextremity Solutions has obtained ISO 13485 certification of its quality management system and CE Mark approval for the NEXTRA Hammertoe Correction System. Nextremity release

And Finally... Researchers have used CT imaging to reproduce a 1704 Stradivarius violin. Story

Suggested Articles

Testing company LumiraDx is selling its pandemic virus rapid test across the U.K. targeting individuals without any COVID-19 symptoms.

The FDA has given genomics firm Helix a wider emergency use authorization for its pandemic test.

Celltrion has nabbed a speedy preapproval for its quick pandemic virus test as it forecasts high demand.